Insider · CIK 0001551966

Hopfner Robert Lorne

CIK 0001551966 Name as filed on the most recent filing

Filed as Hopfner Robert Lorne (17)

52 transaction lines · from 17 filings · filed 2020-06-16 to 2025-12-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

52 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-12-19 Evommune, Inc.
EVMN
P, Open-market purchase 1,000 acquired 17.35 17,350.00 Form 4, filing 0001012975-25-000937
2023-08-01 Inozyme Pharma, Inc.
INZY
P, Open-market purchase 714,285 acquired 4.80 3,428,568.00 Form 4, filing 0000950170-23-038268
2023-08-01 Inozyme Pharma, Inc.
INZY
P, Open-market purchase 119,048 acquired 4.80 571,430.40 Form 4, filing 0000950170-23-038268
2023-05-12 Inozyme Pharma, Inc.
INZY
P, Open-market purchase 228,702 acquired 6.25 1,429,387.50 Form 4, filing 0001209191-23-029521
2023-05-11 Inozyme Pharma, Inc.
INZY
P, Open-market purchase 219,230 acquired 6.48 1,420,610.40 Form 4, filing 0001209191-23-029521
2023-03-29 Inozyme Pharma, Inc.
INZY
P, Open-market purchase 344,592 acquired 4.54 1,563,724.04 Form 4, filing 0001209191-23-021647
2023-03-28 Inozyme Pharma, Inc.
INZY
P, Open-market purchase 156,766 acquired 4.16 652,334.68 Form 4, filing 0001209191-23-021559
2023-03-27 Inozyme Pharma, Inc.
INZY
P, Open-market purchase 51,074 acquired 3.70 188,728.64 Form 4, filing 0001209191-23-021559
2022-04-19 Inozyme Pharma, Inc.
INZY
P, Open-market purchase 1,070,000 acquired 3.69 3,948,300.00 Form 4, filing 0001209191-22-024919
2021-08-02 Rallybio Corp
RLYB
P, Open-market purchase 576,923 acquired 13.00 7,499,999.00 Form 4, filing 0000899243-21-031635
2021-02-10 Vaxcyte, Inc.
PCVX
S, Open-market sale 37,271 disposed 25.75 959,728.25 Form 4, filing 0001062993-21-001201
2021-02-10 Vaxcyte, Inc.
PCVX
S, Open-market sale 26,688 disposed 26.78 714,704.64 Form 4, filing 0001062993-21-001201
2021-02-10 Vaxcyte, Inc.
PCVX
S, Open-market sale 7,567 disposed 27.64 209,151.88 Form 4, filing 0001062993-21-001201
2021-02-10 Vaxcyte, Inc.
PCVX
S, Open-market sale 6,632 disposed 28.66 190,073.12 Form 4, filing 0001062993-21-001201
2021-02-09 Vaxcyte, Inc.
PCVX
S, Open-market sale 93,740 disposed 28.75 2,695,025.00 Form 4, filing 0001062993-21-001201
2021-02-09 Vaxcyte, Inc.
PCVX
S, Open-market sale 88,756 disposed 28.07 2,491,380.92 Form 4, filing 0001062993-21-001201
2021-02-09 Vaxcyte, Inc.
PCVX
S, Open-market sale 38,248 disposed 27.12 1,037,285.76 Form 4, filing 0001062993-21-001201
2021-02-08 Vaxcyte, Inc.
PCVX
S, Open-market sale 50,874 disposed 25.64 1,304,409.36 Form 4, filing 0001062993-21-001201
2021-02-08 Vaxcyte, Inc.
PCVX
S, Open-market sale 28,922 disposed 26.06 753,707.32 Form 4, filing 0001062993-21-001201
2021-02-03 Vaxcyte, Inc.
PCVX
S, Open-market sale 2,768 disposed 25.06 69,366.08 Form 4, filing 0001062993-21-000894
2021-02-02 Vaxcyte, Inc.
PCVX
S, Open-market sale 14,234 disposed 25.13 357,700.42 Form 4, filing 0001062993-21-000894
2021-01-28 Vaxcyte, Inc.
PCVX
S, Open-market sale 2,000 disposed 25.07 50,140.00 Form 4, filing 0001062993-21-000781
2021-01-27 Vaxcyte, Inc.
PCVX
S, Open-market sale 2,140 disposed 25.30 54,142.00 Form 4, filing 0001062993-21-000662
2021-01-26 Vaxcyte, Inc.
PCVX
S, Open-market sale 16,769 disposed 25.23 423,081.87 Form 4, filing 0001062993-21-000662
2021-01-26 Vaxcyte, Inc.
PCVX
S, Open-market sale 1,373 disposed 26.13 35,876.49 Form 4, filing 0001062993-21-000662
2021-01-25 Vaxcyte, Inc.
PCVX
S, Open-market sale 19,511 disposed 25.61 499,676.71 Form 4, filing 0001062993-21-000662
2021-01-25 Vaxcyte, Inc.
PCVX
S, Open-market sale 15,461 disposed 26.07 403,068.27 Form 4, filing 0001062993-21-000662
2021-01-22 Vaxcyte, Inc.
PCVX
S, Open-market sale 11,383 disposed 25.16 286,396.28 Form 4, filing 0001062993-21-000557
2021-01-21 Vaxcyte, Inc.
PCVX
S, Open-market sale 100 disposed 25.11 2,511.00 Form 4, filing 0001062993-21-000557
2021-01-20 Vaxcyte, Inc.
PCVX
S, Open-market sale 19,046 disposed 25.35 482,816.10 Form 4, filing 0001062993-21-000557
2021-01-19 Vaxcyte, Inc.
PCVX
S, Open-market sale 42,516 disposed 25.55 1,086,283.80 Form 4, filing 0001062993-21-000448
2021-01-19 Vaxcyte, Inc.
PCVX
S, Open-market sale 7,000 disposed 26.05 182,350.00 Form 4, filing 0001062993-21-000448
2021-01-15 Vaxcyte, Inc.
PCVX
S, Open-market sale 22,869 disposed 25.74 588,648.06 Form 4, filing 0001062993-21-000448
2021-01-15 Vaxcyte, Inc.
PCVX
S, Open-market sale 3,808 disposed 26.05 99,198.40 Form 4, filing 0001062993-21-000448
2021-01-14 Vaxcyte, Inc.
PCVX
S, Open-market sale 14,918 disposed 25.88 386,077.84 Form 4, filing 0001062993-21-000448
2021-01-13 Vaxcyte, Inc.
PCVX
S, Open-market sale 26,010 disposed 25.90 673,659.00 Form 4, filing 0001062993-21-000354
2021-01-13 Vaxcyte, Inc.
PCVX
S, Open-market sale 3,100 disposed 26.34 81,654.00 Form 4, filing 0001062993-21-000354
2021-01-12 Vaxcyte, Inc.
PCVX
S, Open-market sale 17,666 disposed 26.35 465,499.10 Form 4, filing 0001062993-21-000354
2021-01-12 Vaxcyte, Inc.
PCVX
S, Open-market sale 901 disposed 27.05 24,372.05 Form 4, filing 0001062993-21-000354
2021-01-11 Vaxcyte, Inc.
PCVX
S, Open-market sale 24,980 disposed 26.69 666,716.20 Form 4, filing 0001062993-21-000354
2021-01-11 Vaxcyte, Inc.
PCVX
S, Open-market sale 12,480 disposed 25.42 317,241.60 Form 4, filing 0001062993-21-000354
2021-01-11 Vaxcyte, Inc.
PCVX
S, Open-market sale 12,206 disposed 27.02 329,806.12 Form 4, filing 0001062993-21-000354
2021-01-08 Vaxcyte, Inc.
PCVX
S, Open-market sale 31,468 disposed 26.43 831,699.24 Form 4, filing 0001062993-21-000219
2021-01-08 Vaxcyte, Inc.
PCVX
S, Open-market sale 8,944 disposed 27.08 242,203.52 Form 4, filing 0001062993-21-000219
2021-01-08 Vaxcyte, Inc.
PCVX
S, Open-market sale 200 disposed 28.23 5,646.00 Form 4, filing 0001062993-21-000219
2021-01-07 Vaxcyte, Inc.
PCVX
S, Open-market sale 24,524 disposed 27.75 680,541.00 Form 4, filing 0001062993-21-000219
2021-01-07 Vaxcyte, Inc.
PCVX
S, Open-market sale 22,587 disposed 28.80 650,505.60 Form 4, filing 0001062993-21-000219
2021-01-07 Vaxcyte, Inc.
PCVX
S, Open-market sale 469 disposed 29.51 13,840.19 Form 4, filing 0001062993-21-000219
2021-01-06 Vaxcyte, Inc.
PCVX
S, Open-market sale 34,913 disposed 29.24 1,020,856.12 Form 4, filing 0001062993-21-000219
2021-01-06 Vaxcyte, Inc.
PCVX
S, Open-market sale 22,507 disposed 29.99 674,984.93 Form 4, filing 0001062993-21-000219

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 12
  • Open-market sale 40
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Hopfner Robert Lorne, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001551966

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.